Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study.
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study.
复制标题
DOI:
10.1161/jaha.122.029052
复制
发表时间:
2023-06-06
影响因子:
5.4
通讯作者:
中科院分区:
文献类型:
--
作者:
Clinical practice recommendations for participation in sports and exercise among young competitive athletes with cardiovascular conditions at risk for sudden death are based largely on expert consensus with a paucity of prospective outcomes data. Recent guidelines have taken a more permissive approach, using a shared decision‐making model. However, the impact and outcomes of this strategy remain unknown. The ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) study is a prospective, multicenter, longitudinal, observational cohort study designed to monitor clinical outcomes in athletes with potentially life‐threatening cardiovascular conditions. The study will assess sports eligibility decision‐making, exercise habits, psychosocial well‐being, and long‐term cardiovascular outcomes among young competitive athletes with cardiovascular conditions. Competitive athletes aged 18 to <35 years diagnosed with a confirmed cardiovascular condition or borderline finding with potential increased risk of major adverse cardiovascular events are eligible. Outcomes will be monitored for an initial 5‐year follow‐up period or until age 35, and metrics of psychosocial well‐being and composite adverse cardiovascular events including arrhythmias, sudden cardiac arrest/sudden cardiac death, and evidence of disease progression will be compared among athletes who continue versus discontinue competitive sports participation. The ORCCA study aims to assess the process and results of return to sport decision‐making and to monitor major adverse cardiovascular events, exercise habits, and the psychosocial well‐being among young competitive athletes diagnosed with confirmed cardiovascular conditions or borderline findings with potential increased risk of major adverse cardiovascular events. The results of this work will generate an evidence base to inform future guidelines.
影响因子:
1.3
作者:
Petek BJ;Moulson N;Baggish AL;Drezner JA;Harmon KG;Klein CF;Kliethermes SA;Patel MR;Churchill TW
通讯作者:
Churchill TW